ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1455

Collagen-Induced Arthritis and Uveitis in Mice Lacking TNF Receptors

Chiharu Iwahashi1, Minoru Fujimoto2, Tomoharu Ohkawara3, Hayato Urushima1, Satoshi Serada1 and Tetsuji Naka4, 1Laboratory for Immune Signal, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan, 2Laboratry of immune signal, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan, 3Laboratory for immune signal, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, Japan, 4Laboratory for immune signal, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Arthritis, Collagen, tumor necrosis factor (TNF) and uveitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Animal Models - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Tumor necrosis factor (TNF) is a critical effector of the autoimmune inflammation in rheumatoid arthritis (RA) and uveitis. TNF inhibitors are preferably used in the treatment of these autoimmune diseases. However, TNF inhibitors are not always effective in treating RA. Moreover, previous reports showed that some TNF inhibitors may even accelerate comorbid uveitis in RA patients. Therefore, it is very important to know the precise role of TNF signaling in RA and uveitis. TNF signals are mediated by two structurally related, but functionally distinct, receptors, p55 (TNFR1) and p75 (TNFR2). It has already been shown that genetic disruption of the TNF p55 receptor in mice can reduce the severity of collagen-induced arthritis (CIA) and experimental autoimmune uveitis (EAU), murine models of autoimmune arthritis and uveitis, respectively. However, it remains unclear whether mice lacking p75 or mice lacking both p55 and p75 are also resistant to CIA and EAU. In this study, we aimed to dissect the role of TNF signaling through the TNF p55 or p75 receptor in the development of EAU and CIA.

Methods: The p55-/-, p75-/-, and p55-/-p75-/- mice on a C57BL/6 background were generated by successive backcrossing to C57BL/6 for ten generations. EAU was initiated by immunization with interphotoreceptor retinoid binding protein (IRBP) in complete Freund’s adjuvant (CFA) and administration of pertussis toxin. CIA was induced by immunizing these mice with type II collagen in CFA twice. Clinical examination was performed and severities of EAU and CIA were assessed using clinical scoring system.

Results: In EAU, the severity in p55-/- mice was reduced compared to that in control WT mice, as described previously. In contrast, EAU in p75-/- mice was similar to, or slightly more severe than that in WT mice. Mice lacking both p55 and p75 did not develop a typical acute disease but exhibited delayed-onset uveitis. In CIA, p55-/- mice were protected from arthritis. In contrast, the severity of CIA in p75-/- mice tended to be increased compared to that in control WT mice. Mice lacking both p55 and p75 developed less severe arthritis than WT mice.

Conclusion: Unlike p55-/- mice, p75-/- mice retained susceptibility to CIA and EAU. TNF signaling through p75 might contribute to limit inflammation in CIA and EAU. Antagonists selective to p55 may be advantageous for the treatment of autoimmune arthritis and uveitis.


Disclosure: C. Iwahashi, None; M. Fujimoto, None; T. Ohkawara, None; H. Urushima, None; S. Serada, None; T. Naka, None.

To cite this abstract in AMA style:

Iwahashi C, Fujimoto M, Ohkawara T, Urushima H, Serada S, Naka T. Collagen-Induced Arthritis and Uveitis in Mice Lacking TNF Receptors [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/collagen-induced-arthritis-and-uveitis-in-mice-lacking-tnf-receptors/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/collagen-induced-arthritis-and-uveitis-in-mice-lacking-tnf-receptors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology